Skip to main content
VCbacked
Log inGet Started

Marsi Bionics

Vaciamadrid, Spain

Marsi-Bionics develops and sells self-adaptive gait exoskeletons and robotic orthoses for clinical rehabilitation and mobility assistance.

$4.9M raised
Jun 2023
Venture - Series Unknown
Health CareInformation TechnologyManufacturingRehabilitationRobotics

Top Investors

EASMEOrilla Asset ManagementSpanish National Research Council (CSIC)Business AngelION ION

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Marsi Bionics

How much funding has Marsi Bionics raised?
Marsi Bionics has raised $4.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
Who are Marsi Bionics's investors?
Marsi Bionics's investors include EASME, Orilla Asset Management, Spanish National Research Council (CSIC), Business Angel, ION ION.
Where is Marsi Bionics headquartered?
Marsi Bionics is headquartered in Vaciamadrid, Spain.
What does Marsi Bionics do?
Marsi-Bionics develops and sells self-adaptive gait exoskeletons and robotic orthoses for clinical rehabilitation and mobility assistance.
What stage is Marsi Bionics at?
Marsi Bionics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Marsi Bionics — Funding & Investors." VCBacked, June 30, 2023, https://www.vcbacked.co/company/marsi-bionics. Accessed June 3, 2026.
APA
VCBacked. (2023). Marsi Bionics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/marsi-bionics
Wikipedia (cite web)
{{cite web |title=Marsi Bionics — Funding & Investors |url=https://www.vcbacked.co/company/marsi-bionics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K